insights_auto
Pse është rritur 0QF 9,24%?
Zhytu më thellëchevron_right
0QF:FRA
Moderna Inc
182,82 €
arrow_upward
+9,24%(+15,46) 1D
5 tet, 8:35:14 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 0QF...
Hap
169,70 €
I lartë
182,82 €
I ulët
168,62 €
Kapitalizimi i tregut
81,98 mld
Vëllimi mesatar
1,71 mijë
Vëllimi
914,00
Maksimumi 52-javor
183,40 €
Minimumi 52-javor
19,26 €
Numri i punonjësve
5 mijë
Hap
169,70 €
I lartë
182,82 €
I ulët
168,62 €
Kapitalizimi i tregut
81,98 mld
Vëllimi mesatar
1,71 mijë
Vëllimi
914,00
Maksimumi 52-javor
183,40 €
Minimumi 52-javor
19,26 €
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
24/7 Wall St.
·
8 minuta më parë
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
AD HOC NEWS
·
1 orë më parë
Moderna stock after-hours at EUR 180.97: plus 7.29 percent versus prior close
TradingKey
·
1 orë më parë
Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know
Yahoo Finance
·
15 orë më parë
Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?
Profili
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Rreth Moderna Inc
Drejtori ekzekutivStephane Bancel
Punonjësit4,7 mijë
Themeluar mësht 2010
Selia-
Sektori-
Uebsajtimodernatx.com